Table 2. Cardiac involvement and outcome of MIS-C [33-35,78,79,81-83]

	Initial presentation (%)	Recovery (%)	Follow up time
Ventricular systolic dysfunction	34%–75%	68.5%–76%	At discharge
		91%–95%	30 days
		99.4%–100%	90 days
Coronary arterial abnormalities	17%–48%	71.4%–79.1%	30 days
		99%–100%	90 days
ECG abnormalities	35%–67%	77%	At discharge
		95%	30 days
Bradyarrhythmia	16%–20%	83.3%–100%	At discharge
Tachyarrhythmia	1.7%–3.2%	100%	At discharge